|
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits |
1R01HD109750-01 |
|
NICHD |
2022 |
|
Modeling genetic anencephaly with human brain organoids |
1R03HD104901-01A1 |
|
NICHD |
2022 |
|
Feasibility of using remotely-delivered metacognitive strategy training to address cancer-related cognitive impairment in breast cancer |
1R03HD107610-01 |
|
NICHD |
2022 |
|
Newborn screening and treatment monitoring for patients with pyridoxine-dependent epilepsy |
1R21HD104952-01A1 |
|
NICHD |
2022 |
|
Elucidating the causes and consequences of sleep disturbances in children with rare genetic syndromes |
1R21HD107535-01A1 |
|
NICHD |
2022 |
|
Regulation of 22q11 Genes in Embryonic and Adult Forebrain |
2R01HD042182-18A1 |
|
NICHD |
2022 |
|
Predictability in complex object control |
2R37HD087089-06A1 |
|
NICHD |
2022 |
|
Learning difficulties in reading, writing, and mathematics and their co-occurrence with ADHD: Etiology, neuropsychology, and functional outcomes |
3P50HD027802-30S1 |
|
NICHD |
2022 |
|
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome |
4R33HD100934-03 |
|
NICHD |
2022 |
|
Tracking neurocognitive changes during evidence-based reading instruction in typically and atypically developing children |
4R37HD090153-06 |
|
NICHD |
2022 |